市場調查報告書
商品編碼
1256587
驅蟲劑市場 - 2023-2028 年預測Insect Repellent Market - Forecasts from 2023 to 2028 |
全球驅蟲劑市場預計將從 2021 年的 79.87 億美元增長到 2028 年的 118.28 億美元,複合年增長率為 5.77%。
隨著登革熱、瘧疾、基孔肯雅熱、寨卡病毒和黃熱病等疾病在全球範圍內的威脅不斷增加,預計該市場在預測期內將會擴大。 根據世界衛生組織 (WHO) 的一份報告,這些疾病自 2019 年以來一直呈上升趨勢。 例如,每 1000 人中有 59.5 人有感染瘧疾的風險。 據世界衛生組織稱,因此,瘧疾死亡人數從 2014 年的 569,000 人增加到 2020 年的 627,000 人。 此外,近年來全球範圍內用於根除瘧疾的投資和資金也有所增加,據世衛組織報告,2021 年用於控制和消除瘧疾的資金約為 35 億美元。 到 2021 年,全球 40% 的瘧疾投資將通過全球基金進行。 因此,這些控制昆蟲引起的疾病傳播的努力也推動了驅蟲噴霧劑的市場需求。
驅蟲劑市場受到不斷上升的疾病威脅和政府舉措的推動。
推動驅蟲劑解決方案市場需求的主要因素是與昆蟲接觸導致登革熱、瘧疾、基孔肯雅熱、寨卡病毒和黃熱病的疾病威脅越來越大。 此類疾病在全球範圍內暴發,增加了對驅蟲劑解決方案的需求。 例如,世界衛生組織報告稱,2020 年將有 2.41 億瘧疾病例。 此外,據世界衛生組織稱,瘧疾佔五歲以下兒童死亡人數的 7.8%。 人們越來越關注預防此類疾病所需的安全措施。 為了克服這種情況,疫苗的發布和政府機構正在做出各種努力。 例如,世衛組織於 2021 年 4 月發起的 E-2025 倡議旨在支持 25 個國家到 2025 年根除瘧疾。 這建立在 E-2020 倡議的基礎上。
此外,2021 年 10 月,世衛組織批准了 RTS,S 瘧疾疫苗,用於惡性瘧原蟲中度至高度流行地區(例如撒哈拉以南非洲)的兒童。 該建議基於對 RTS,S 的整個數據集的審查,包括自 2019 年以來對加納、肯尼亞和馬拉維 830,000 多名兒童實施的試點項目的結果。 在另一個例子中,世衛組織在 2021 年修訂了其全球瘧疾戰略,以吸收過去五年的經驗教訓。 實現該戰略的目標,包括到 2030 年將全球瘧疾發病率和死亡率降低 90%。
北美主導著驅蟲劑市場。
按地區劃分,儲罐液位監測市場分為北美、南美、歐洲、中東和非洲以及亞太地區。
蟲媒疾病在亞太地區的主要國家印度、印度尼西亞和泰國流行,防止這些疾病傳播的努力正在推動驅蟲噴霧劑的市場需求推高。
驅蟲劑用於預防主要的媒介傳播疾病,例如瘧疾、基孔肯雅熱和登革熱。 印度是此類主要媒介傳播疾病 (VBD) 的地方病,不斷變化的氣候條件加上缺乏必要的預防措施大大增加了此類疾病的流行。 例如,根據國家媒介傳播疾病控制中心的數據,2021 年,印度報告了 193245 例登革熱病例,比 2020 年的 44585 例顯著增加了 333.4%。 此外,因登革熱死亡的人數將從2020年的56人增加到2021年的346人。 這種媒介傳播疾病的增加將增加印度對殺蟲劑的需求,從而推動整個市場的增長。
按銷售渠道劃分,驅蟲劑市場預計將通過在線市場實現強勁增長。
由於分銷渠道的擴展和互聯網普及支持該行業的發展,在線行業呈現出可喜的增長勢頭,尤其是在新興經濟體中。 補充這一細分市場增長的主要因素是消費者對在線購物的偏好和互聯網普及率,尤其是在印度和中國等新興經濟體。 此外,銷售渠道的擴展和在線平台上產品可用性的提高也對擴大市場起到了重要作用。
The market is expected to grow during the forecast period owing to the rising threats across the world of diseases like dengue, malaria, chikungunya, Zika virus, and yellow fever. According to a report by the World Health Organization (WHO), these diseases have been on a rise since 2019. For instance, per 1000 population, 59.5 were at risk of being infected by malaria. Consequently, the number of deaths caused by malaria has increased from 569,000 in 2014 to 627,000 in 2020 according to the World Health Organization. Moreover, the rising investment and funding done in order to eradicate the diseases on a global level have also increased in recent years, with WHO reporting about USD 3.5 billion of funding done in 2021 for malaria control and elimination. Along with that, in 2021, 40% of global malaria investments were received through the Global Fund. Hence, such efforts owing to curb the spread of diseases caused by insects are propelling the market demand for insect repellents as well.
A major factor driving the market demand for insect-repellent solutions is the increasing threat of diseases caused by coming in contact with insects causing dengue, malaria, chikungunya, Zika virus, and yellow fever. The surging incidences of such diseases globally have increased the demand for insect-repellent solutions. For instance, the WHO reported 241 million malaria cases in 2020. Furthermore, according to the World Health Organization, malaria is responsible for a greater proportion (7.8%) of fatalities among children under the age of five. This has led to mounting concern over the safety measures that are required to prevent such diseases. Various initiatives by government institutions, along with the launch of vaccines are being undertaken in order to curb the rising number of cases and spread awareness amongst the citizens. For example, The E-2025 initiative was launched by WHO in April 2021 to assist 25 nations in their attempts to eradicate malaria by 2025. It has been built on the foundation of the E-2020 initiative.
Furthermore, WHO approved the RTS,S malaria vaccine for children in Sub-Saharan Africa and other places with moderate to high P. falciparum malaria transmission in October 2021. The advice was based on an examination of the entire body of data on RTS,S, including the findings of a pilot program in Ghana, Kenya, and Malawi that has reached over 830 000 children since 2019. In another instance, WHO modified its worldwide malaria strategy in 2021 to incorporate lessons learned during the previous five years. Meeting the strategy's objectives, which include reducing global malaria incidence and fatality rates by 90% by 2030.
By geography, the tank level monitoring market has been segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.
The growing prevalence of insect-borne diseases in major Asia Pacific countries namely India, Indonesia, and Thailand coupled with a growing initiative to prevent the increase of such diseases is driving the market demand for insect repellent.
Insect repellents are used to provide protection from major vector-borne diseases namely malaria, chikungunya, and dengue. India is endemic to such major vector-borne diseases (VBD), and with the fluctuations in climatic conditions coupled with a lack of taking necessary precautions, the country is witnessing a significant increase in the prevalence of such disease. For instance, according to the National Center for Vector Borne Diseases Control, in 2021, India reported 1,93,245 cases of dengue which represented a significant increase of 333.4% over 44,585 cases reported in 2020. Furthermore, as per the same source, the deaths reported due to dengue stood at 346 in 2021 in comparison to 56 deaths reported in 2020. Such an increase in the vector-borne disease will boost the demand for insect repellent in India, thereby propelling the overall market growth.
The online segment will witness promising growth since the expansion of distribution channels and growing internet penetration, particularly in developing economies which are supporting the growth of this segment during the given time frame. The key factors supplementing the growth of this segment include the inclination of consumers to make purchases online coupled with the booming penetration of the internet primarily in developing economies such as India and China among others. Moreover, the expansion of sales channels and the growing availability of these products on online platforms also play a significant role in shaping market expansion.